Structure-Based Design of 1-Heteroaryl-1,3-propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 Antagonists-Reference-Cited by-同舟云学术

Structure-Based Design of 1-Heteroaryl-1,3-propanediamine Derivatives as a Novel Series of CC-Chemokine Receptor 5 Antagonists

Published:2018-09-20 Issue:21 Volume:61 Page:9621-9636
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Peng Panfeng¹,Chen Huan²¹,Zhu Ya¹,Wang Zhilong¹,Li Jian¹,Luo Rong-Hua²¹,Wang Jiang¹,Chen Liang¹,Yang Liu-Meng²¹,Jiang Hualiang¹,Xie Xin¹,Wu Beili¹,Zheng Yong-Tang²¹,Liu Hong¹^ORCID

Affiliation:

1. University of Chinese Academy of Sciences, Number 19A Yuquan Road, Beijing 100049, China

2. Key Laboratory of Bioactive Peptides of Yunnan Province, Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences, KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, Yunnan 650223, China

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Chinese Academy of Sciences

China Marine Commonweal Research Project

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b01077

Reference27 articles.